Main Article Content

New Trends in Neuro-protection in Glaucoma


Andrew U. Omaka
Amarachi Ezeigbo

Abstract

Recent advancements in neuroprotection for glaucoma have seen a shift towards multifaceted approaches targeting various aspects of  the disease's pathophysiology. Traditional strategies were primarily focused on lowering intraocular pressure (IOP) but emerging trends  highlight the importance of preserving retinal ganglion cells (RGCs) and their axons. Novel therapeutics aim to enhance neurotrophic  support, reduce excitotoxicity, and mitigate oxidative stress, complementing IOP-lowering therapies for comprehensive management.  Stem cell therapies, neurotrophic factors, and gene therapies show promise in promoting RGC survival and axonal regeneration.  Additionally, the repurposing of existing drugs, such as calcium channel blockers and anti-inflammatory agents, for neuro-protection in  glaucoma underscores the importance of exploring diverse mechanisms. These innovative approaches represent a paradigm shift in  glaucoma management, emphasizing the need for a holistic approach targeting both IOP and neuroprotection to preserve vision  effectively.


Journal Identifiers


eISSN: 0795-0039
print ISSN: 0795-0039